Delcath Systems Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 3841 http://delcath.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems Inc

50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 - Jul 8th, 2021 3:20 pm
Delcath Systems to Present at Access to Giving Virtual Conference on July 13, 2021 at 3 p.m. ET - Jul 7th, 2021 1:00 pm
Delcath Systems Set to Join Russell Microcap® Index - Jun 8th, 2021 1:00 pm
Delcath Systems' Hepzato Achieves 44% Best Overall Response Compared to Best Alternative Care in Eye Cancer - Jun 7th, 2021 4:21 pm
Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting - Jun 7th, 2021 11:30 am
Delcath Systems to Present at LD Micro Virtual Investor Conference on June 10, 2021, at 2:30pm ET - Jun 3rd, 2021 1:00 pm
Delcath Systems to Present at Jefferies Virtual Healthcare Conference - May 26th, 2021 1:00 pm
Moving Average Crossover Alert: Delcath Systems (DCTH) - May 24th, 2021 10:17 am
Delcath Systems, Inc. Announces First Quarter 2021 Results - May 11th, 2021 12:00 pm
Delcath Systems, Inc. to Host Earnings Call - May 11th, 2021 9:45 am
Who Has Been Buying Delcath Systems, Inc. (NASDAQ:DCTH) Shares? - May 3rd, 2021 6:33 am
Delcath Systems Schedules Conference Call to Report 2021 First Quarter Financial Results - Apr 30th, 2021 8:01 pm
Delcath Systems Announces Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 30th, 2021 1:00 pm
Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom - Apr 21st, 2021 12:38 pm
Delcath Systems, Inc. Shares Additional Information Regarding FOCUS Trial Power Calculation - Mar 31st, 2021 6:55 pm
Delcath Stock Moves Higher After Hepzato Achieves ORR Of 29.2% Beating Prespecified Threshold In Eye Cancer Study - Mar 31st, 2021 12:06 pm
Delcath Systems, Inc. Announces Fourth Quarter 2020 Results, Highlights Preliminary Positive FOCUS Trial Results; Conference Call Today at 8:00am Eastern Time - Mar 31st, 2021 11:45 am
Delcath Systems, Inc. Announces Positive Preliminary Results from Phase 3 FOCUS Trial of HEPZATO in Patients with Metastatic Ocular Melanoma - Mar 31st, 2021 11:30 am
Delcath Systems Schedules Conference Call to Report 2020 Fourth Quarter Financial Results - Mar 24th, 2021 8:01 pm
Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Mar 8th, 2021 2:00 pm